Safety of Complementary Medicines

A special issue of Medicines (ISSN 2305-6320).

Deadline for manuscript submissions: closed (30 November 2018) | Viewed by 79401

Special Issue Editor

E-Mail Website
Guest Editor
National Institute of Complementary Medicine (NICM), Western Sydney University, Penrith, NSW 2751, Australia
Interests: anti-inflammatory; antioxidant; anticancer; bioactive compounds; plant extracts; pharmacology
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

Complementary medicines (CM) include a diverse range of therapies and products, such as acupuncture, naturopathy, vitamin and mineral supplements, mind–body practices, etc. These therapies have long been used in many countries, and, in recent times, are increasingly used in communities for preventing or managing various diseases and conditions. Some CM therapies are based on traditional practice systems, such as traditional Chinese medicine and Ayurvedic medicine, others are related to the conventional medical practice as supportive therapies. The health benefit of CM is mainly supported by traditional evidence with limited scientific evidence available. On the other hand, there are frequent concerns on their quality and safety which are often associated with product quality, improper practice, contaminants and toxicities of certain ingredients in CM products, such as pesticide residues, heavy metal and microbial contaminants in herbal medicines. It is important to understand the safety aspects of CM in order to minimise the potential risks involved and improve the quality practice/use of CM therapies and products.

This Special Issue invites original contributions, including review articles and practice guidelines, on all aspects of complementary medicines, including basic and clinical research on CM practice and related products, such as surveys, herbal toxicity, drug–herb interactions, contaminants and detections, as well as relevant quality control standards.

Prof. Dr. Chun Guang Li
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Medicines is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1400 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.


  • complementary medicines
  • traditional Chinese medicine
  • Ayurvedic medicine
  • vitamin and mineral supplements
  • acupuncture
  • herbal toxicity
  • herbal-drug interaction
  • contaminant & adulation
  • adverse reactions

Published Papers (7 papers)

Order results
Result details
Select all
Export citation of selected articles as:


Jump to: Review, Other

18 pages, 1441 KiB  
PharmActa: Empowering Patients to Avoid Clinical Significant Drug–Herb Interactions
Medicines 2019, 6(1), 26; - 16 Feb 2019
14 pages, 2485 KiB  
Guggulsterone Activates Adipocyte Beiging through Direct Effects on 3T3-L1 Adipocytes and Indirect Effects Mediated through RAW264.7 Macrophages
Medicines 2019, 6(1), 22; - 31 Jan 2019
10 pages, 535 KiB  
Pilot Studies on Two Complementary Bath Products for Atopic Dermatitis Children: Pine-Tar and Tea
Medicines 2019, 6(1), 8; - 08 Jan 2019
16 pages, 1123 KiB  
Clinical Safety of Combined Targeted and Viscum album L. Therapy in Oncological Patients
Medicines 2018, 5(3), 100; - 06 Sep 2018


Jump to: Research, Other

10 pages, 251 KiB  
Current Status and Major Challenges to the Safety and Efficacy Presented by Chinese Herbal Medicine
Medicines 2019, 6(1), 14; - 18 Jan 2019
12 pages, 467 KiB  
Medicinal Cannabis—Potential Drug Interactions
Medicines 2019, 6(1), 3; - 23 Dec 2018


Jump to: Research, Review

8 pages, 577 KiB  
Case Report
Use of Acupuncture in an Infant with Restlessness and Agitation
Medicines 2018, 5(2), 55; - 13 Jun 2018
Back to TopTop